FDA Clearance Tracker · K180349
AssureTech Panel Dip Tests, AssureTech Quick Cup Tests
Last checked: Nov 20, 2026Latest source record: Apr 5, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Apr 5, 2018
Substantially Equivalent
Time to decision
56 days
Received Feb 8, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K180349
- Device name
- AssureTech Panel Dip Tests, AssureTech Quick Cup Tests
- Applicant
- Assure Tech. (Hangzhou) Co, Ltd.
- Applicant location
- Hangzhou, CN
- Received
- Feb 8, 2018
- Decided
- Apr 5, 2018
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Test, Amphetamine, Over The Counter (NFT)
- Device class
- Class II
- Regulation
- 21 CFR 862.3100
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NFT. The earliest in FDA's data is K170049, decided May 2, 2017.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K180349
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Assure Tech. (Hangzhou) Co, Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K233174 · Decided Feb 5, 2024 · 130 days after receipt
Device type: Kit, Test, Pregnancy, Hcg, Over The Counter (LCX) · Laboratory Medicine & Pathology
K201630 · Decided Aug 12, 2021 · 422 days after receipt
Device type: Enzyme Immunoassay, Opiates (DJG) · Laboratory Medicine & Pathology
K181768 · Decided Aug 20, 2018 · 48 days after receipt
Device type: Test, Amphetamine, Over The Counter (NFT) · Laboratory Medicine & Pathology
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.